InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-48.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by File Justin J., Chief Financial Officer. Officer active across 2 companies, notably Evofem Biosciences, Inc.. In total, 9 disclosures have been logged. Split: 4 buys · 0 sell. Total volume traded: €68k. History available since 20 May 2021. The latest transaction was filed on 18 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
450,000 shares0Common StockSEC:0001618835-22-000030:0
120,000 shares0Common StockSEC:0001618835-22-000005
120,000 shares0Common StockSEC:0001618835-22-000005:0
40,594 shares@ US$0.371.55% mcap13.6% of flowCommon StockSEC:0001618835-21-000272:0
Ideal exit: 16 Sept 2022 (T+270)
40,594 shares@ US$0.3713.6% of flowCommon StockSEC:0001618835-21-000272
Ideal exit: 16 Sept 2022 (T+270)
24,500 shares@ US$1.032.41% mcap21.2% of flowCommon StockSEC:0001618835-21-000148:0
Ideal exit: 7 Mar 2022 (T+270)
24,500 shares@ US$1.0321.2% of flowCommon StockSEC:0001618835-21-000148
Ideal exit: 7 Mar 2022 (T+270)
42,280 shares@ US$0.863.45% mcap30.4% of flowCommon StockSEC:0001618835-21-000134:0
42,280 shares@ US$0.86100.0% of flowCommon StockSEC:0001618835-21-000134
9 of 9 declarations
About File Justin J.
Justin J. File is the Chief Financial Officer at Evofem Biosciences, Inc. In this role, he is responsible for managing the company's finances, including financial planning and performance analysis. Justin plays a key role in preparing financial reports and managing financial risks.
